AI assistant
Murray International Trust PLC — Director's Dealing 2018
Jul 3, 2018
4594_dirs_2018-07-03_9ac6e49d-8499-4cb4-bbc6-fd737add9bca.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4336T
Murray International Trust PLC
03 July 2018
Murray International Trust PLC
Legal Entity Identifier: 549300BP77JO5Y8LM553
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
DR KEVIN CARTER
2
Reason for the notification
a)
Position/status
NON EXECUTIVE DIRECTOR
b)
Initial notification/ Amendment
INITIAL NOTIFICATION
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
MURRAY INTERNATIONAL TRUST PLC
b)
LEI
549300BP77JO5Y8LM553
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
ORDINARY 25P SHARES
GB0006111909
b)
Nature of the transaction
SHARE PURCHASE
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £11.31792 PER SHARE | 5,000 |
d)
Aggregated information
- Aggregated volume
- Price
5,000 ORDINARY SHARES OF 25P EACH
£56,589.60 TOTAL PRICE
e)
Date of the transaction
2018-07-03
f)
Place of the transaction
LONDON STOCK EXCHANGE, MAIN MARKET (XLON)
Following this transaction the total declarable holding of Dr KEVIN CARTER is 45,000 Ordinary Shares of 25p each
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHLLFIIDFIVIIT